يعرض 81 - 90 نتائج من 311 نتيجة بحث عن '"Harm van Tinteren"', وقت الاستعلام: 1.24s تنقيح النتائج
  1. 81

    المساهمون: Graduate School, Radiology and Nuclear Medicine, AGEM - Digestive immunity, AGEM - Re-generation and cancer of the digestive system, APH - Mental Health, CCA - Cancer Treatment and Quality of Life, ARD - Amsterdam Reproduction and Development

    المصدر: European journal of cancer (Oxford, England, 128, 38-46. Elsevier Limited

  2. 82

    المصدر: European journal of cancer (Oxford, England : 1990). 127

  3. 83

    المساهمون: Health Technology & Services Research, Klinische Psychologie (Psychologie, FMG), Targeted Gynaecologic Oncology (TARGON), Obstetrics and Gynaecology, CCA - Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Surgery

    المصدر: Koole, S N, van Lieshout, C, van Driel, W J, van Schagen, E, Sikorska, K, Kieffer, J M, Schagen van Leeuwen, J H, Schreuder, H W R, Hermans, R H, de Hingh, I H, van der Velden, J, Arts, H J, Massuger, L F A G, Aalbers, A G, Verwaal, V J, Van de Vijver, K K, Aaronson, N K, van Tinteren, H, Sonke, G S, van Harten, W H & Retèl, V P 2019, ' Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 37, no. 23, pp. 2041-2050 . https://doi.org/10.1200/JCO.19.00594Test
    Journal of Clinical Oncology, 37, 23, pp. 2041
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37(23), 2041. American Society of Clinical Oncology
    Journal of clinical oncology, 37(23), 2041-2050. American Society of Clinical Oncology
    Journal of Clinical Oncology, 37, 2041
    Journal of Clinical Oncology, 37(23), 2041-2050. American Society of Clinical Oncology
    Journal of Clinical Oncology, 37(23), 2041-2050. AMER SOC CLINICAL ONCOLOGY
    Obstetrical and Gynecological Survey, 74(10), 592-593. Lippincot, Williams & Wilkins
    Obstetrical and Gynecological Survey, 74(10), 592-593. Lippincott Williams and Wilkins

    وصف الملف: application/pdf; image/pdf

  4. 84
  5. 85

    المساهمون: Hematology, CCA - Cancer Treatment and quality of life, Stem Cell Aging Leukemia and Lymphoma (SALL), CCA - Cancer Treatment and Quality of Life, Clinical Haematology

    المصدر: Haematologica, 104(4), E151-E153. Ferrata Storti Foundation
    Haematologica, 104(4), e151-e153. Ferrata Storti Foundation
    Haematologica, 104(4), e151-e153. FERRATA STORTI FOUNDATION
    Hagenbeek, A, Mooij, H, Zijlstra, J, Lugtenburg, P, van Imhoff, G, Nijland, M, Tonino, S, Hutchings, M, Spiering, M, Liu, R, van Tinteren, H & Kersten, M J 2019, ' Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical hodgkin lymphoma : The HOVON/LLPC transplant brave study ', Haematologica, vol. 104, no. 4, pp. e151-e153 . https://doi.org/10.3324/haematol.2018.196899Test, https://doi.org/10.3324/haematol.2018.196899Test

    وصف الملف: application/pdf

  6. 86

    المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

    المصدر: Lacas, B, Bourhis, J, Overgaard, J, Zhang, Q, Grégoire, V, Nankivell, M, Zackrisson, B, Szutkowski, Z, Suwiński, R, Poulsen, M, O'Sullivan, B, Corvò, R, Laskar, S G, Fallai, C, Yamazaki, H, Dobrowsky, W, Cho, K H, Garden, A S, Langendijk, J A, Viegas, C M P, Hay, J, Lotayef, M, Parmar, M K B, Aupérin, A, van Herpen, C, Maingon, P, Trotti, A M, Grau, C, Pignon, J-P, Blanchard, P, MARCH Collaborative Group & Johansen, J 2017, ' Role of radiotherapy fractionation in head and neck cancers (MARCH) : an updated meta-analysis ', Lancet Oncology, vol. 18, no. 9, pp. 1221-1237 . https://doi.org/10.1016/S1470-2045Test(17)30458-8
    Lancet Oncology, 18, 1221-1237
    Lancet Oncology, 18, 9, pp. 1221-1237
    Lancet Oncology, 18(9), 1221-1237. ELSEVIER SCIENCE INC
    Lacas, B, Bourhis, J, Overgaard, J, Zhang, Q, Grégoire, V, Nankivell, M, Zackrisson, B, Szutkowski, Z, Suwiński, R, Poulsen, M, O'Sullivan, B, Corvò, R, Laskar, S G, Fallai, C, Yamazaki, H, Dobrowsky, W, Cho, K H, Garden, A S, Langendijk, J A, Viegas, C M P, Hay, J, Lotayef, M, Parmar, M K B, Aupérin, A, van Herpen, C, Maingon, P, Trotti, A M, Grau, C, Pignon, J P & Blanchard, P 2017, ' Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis ', Lancet Oncology, vol. 18, no. 9, pp. 1221-1237 . https://doi.org/10.1016/S1470-2045Test(17)30458-8

    وصف الملف: application/pdf

  7. 87
    دورية أكاديمية
  8. 88

    المساهمون: Princess Máxima Center for Pediatric Oncology, University Medical Center [Utrecht], Saarland University Hospital (UKS), Département de cancérologie de l'enfant et de l'adolescent [Gustave Roussy], Institut Gustave Roussy (IGR), Great Ormond Street Institute of Child Health (UCL), University College of London [London] (UCL), Instituto Nacional de Câncer [Rio de Janeiro] (INCA), Hospital Universitario Virgen del Rocío [Sevilla], Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (COMPO), Inria Sophia Antipolis - Méditerranée (CRISAM), Institut National de Recherche en Informatique et en Automatique (Inria)-Institut National de Recherche en Informatique et en Automatique (Inria)-Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de radiothérapie - [Hôpital de la Timone - Hôpital Nord - APHM], Hôpital de la Timone [CHU - APHM] (TIMONE)- Hôpital Nord [CHU - APHM], Centre de Recherche en Cancérologie de Marseille (CRCM), The Christie NHS Foundation Trust [Manchester, Royaume-Uni], Pédiatrie et oncologie pédiatrique [Hôpital de la Timone - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Department of Radiotherapy [Utrecht], Princess Máxima Center for Pediatric Oncology [Utrecht, Pays-Bas], Department of Paediatric Oncology and Haematology, Saarland University Hospital, Trial and Data Center, Princess Máxima Center for Pediatric Oncology [Utrecht, Netherlands], Developmental Biology & Cancer Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, Partenaires INRAE-Partenaires INRAE, Unidad de Oncología Pediátrica

    المصدر: Cancers
    Cancers, 2021, 13 (5), pp.976. ⟨10.3390/cancers13050976⟩
    Cancers, MDPI, 2021, 13 (5), pp.976. ⟨10.3390/cancers13050976⟩
    Cancers, Vol 13, Iss 976, p 976 (2021)
    Volume 13
    Issue 5

    وصف الملف: application/pdf

  9. 89

    المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, CCA - Cancer Treatment and quality of life, Radiation Oncology, Pulmonary medicine, Radiotherapy

    المصدر: Lung Cancer, 108, 150-153. ELSEVIER IRELAND LTD
    Lung Cancer, 108, 150-153. Elsevier Ireland Ltd
    Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150-153 . https://doi.org/10.1016/j.lungcan.2017.03.007Test
    Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J O, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J A, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150–153 . https://doi.org/10.1016/j.lungcan.2017.03.007Test

    وصف الملف: application/pdf

  10. 90

    المصدر: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
    r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
    instname
    European Journal of Nuclear Medicine and Molecular Imaging